{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T04:55:28Z","timestamp":1792472128403,"version":"4.5.0"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018886","name":"Laborat\u00f3rio Associado para a Qu\u00edmica Verde","doi-asserted-by":"publisher","award":["2024.13556"],"award-info":[{"award-number":["2024.13556"]}],"id":[{"id":"10.13039\/501100018886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005282","name":"Department of Science Technology and Higher Education of Ceara State","doi-asserted-by":"publisher","award":["UI\/BD\/154513\/2023"],"award-info":[{"award-number":["UI\/BD\/154513\/2023"]}],"id":[{"id":"10.13039\/501100005282","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.canlet.2025.218183","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T04:33:28Z","timestamp":1764390808000},"page":"218183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Overcoming radioresistance in prostate cancer by targeting DNA damage repair"],"prefix":"10.1016","volume":"639","author":[{"given":"Ana Catarina","family":"Matos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Miranda-Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Indraccolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Jer\u00f3nimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00edlia","family":"Saraiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2025.218183_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canlet.2025.218183_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.728054","article-title":"Advanced therapeutic options for treatment of metastatic castration resistant prostatic adenocarcinoma","volume":"12","author":"Naseer","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.canlet.2025.218183_bib3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.nucmedbio.2021.03.009","article-title":"Drug and molecular radiotherapy combinations for metastatic castration resistant prostate cancer","volume":"96\u201397","author":"Staniszewska","year":"2021","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.canlet.2025.218183_bib4","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20230334","article-title":"The use of radiotherapy, surgery and chemotherapy in the curative treatment of cancer: results from the FORTY (Favourable Outcomes from RadioTherapY) project","volume":"96","author":"Mee","year":"2023","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.canlet.2025.218183_bib5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1615\/CritRevOncog.2018025946","article-title":"Profiles of radioresistance mechanisms in prostate cancer","volume":"23","author":"Chaiswing","year":"2018","journal-title":"Crit. Rev. Oncog."},{"key":"10.1016\/j.canlet.2025.218183_bib6","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.cell.2015.05.001","article-title":"Integrative clinical genomics of advanced prostate cancer","volume":"161","author":"Robinson","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2025.218183_bib7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41391-019-0153-2","article-title":"Role of the DNA damage response in prostate cancer formation, progression and treatment","volume":"23","author":"Zhang","year":"2019","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.canlet.2025.218183_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22073753","article-title":"Hereditary prostate cancer: genes related, target therapy and prevention","volume":"22","author":"Vietri","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2025.218183_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14225504","article-title":"Radioresistance mechanisms in prostate cancer cell lines surviving ultra-hypo-fractionated EBRT: implications and possible clinical applications","volume":"14","author":"Sideri","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2025.218183_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.177149","article-title":"Targets for improving prostate tumor response to radiotherapy","volume":"986","author":"Li","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.canlet.2025.218183_bib11","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1158\/1078-0432.CCR-22-2340","article-title":"Radiotherapy induces innate immune responses in patients treated for prostate cancers","volume":"29","author":"Cheema","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2025.218183_bib12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1158\/0008-5472.CAN-07-6871","article-title":"Advances in radiotherapy and implications for the next century: a historical perspective","volume":"69","author":"Connell","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.218183_bib13","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nrclinonc.2012.203","article-title":"Past, present, and future of radiotherapy for the benefit of patients","volume":"10","author":"Thariat","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2025.218183_bib14","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1111\/cas.15068","article-title":"Reactive oxygen species in cancer: current findings and future directions","volume":"112","author":"Nakamura","year":"2021","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2025.218183_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14010105","article-title":"Combining nanocarrier-assisted delivery of molecules and radiotherapy","volume":"14","author":"Gomes","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.canlet.2025.218183_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/cells8091105","article-title":"Cellular stress responses in radiotherapy","volume":"8","author":"Kim","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.canlet.2025.218183_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27051540","article-title":"DNA damage clustering after ionizing radiation and consequences in the processing of chromatin breaks","volume":"27","author":"Mladenova","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.canlet.2025.218183_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.749496","article-title":"Clinical and preclinical outcomes of combining targeted therapy with radiotherapy","volume":"11","author":"Elbanna","year":"2021","journal-title":"Front. Oncol."},{"issue":"11","key":"10.1016\/j.canlet.2025.218183_bib19","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41576-019-0151-1","article-title":"DNA sensing by the cGAS\u2013STING pathway in health and disease","volume":"20","author":"Motwani","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.canlet.2025.218183_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1125905","article-title":"Mechanistic rationales for combining immunotherapy with radiotherapy","volume":"14","author":"Chi","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2025.218183_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.971959","article-title":"Enhancing anti-tumour innate immunity by targeting the DNA damage response and pattern recognition receptors in combination with radiotherapy","volume":"12","author":"Chan Wah Hak","year":"2022","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.canlet.2025.218183_bib22","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41391-021-00340-5","article-title":"How to turn up the heat on the cold immune microenvironment of metastatic prostate cancer","volume":"24","author":"Stultz","year":"2021","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.canlet.2025.218183_bib23","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1158\/1078-0432.CCR-13-3229","article-title":"Molecular pathways: overcoming radiation resistance by targeting DNA damage response pathways","volume":"21","author":"Morgan","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2025.218183_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114126","article-title":"Molecular targets that sensitize cancer to radiation killing: from the bench to the bedside","volume":"158","author":"Sriramulu","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2025.218183_bib25","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6829875","article-title":"Prostate cancer radiation therapy: what do Clinicians have to know?","volume":"2016","author":"Vanneste","year":"2016","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.canlet.2025.218183_bib26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2015.2","article-title":"DNA damage and the balance between survival and death in cancer biology","volume":"16","author":"Roos","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2025.218183_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14194874","article-title":"Targeting the DNA damage response and DNA repair pathways to enhance radiosensitivity in colorectal cancer","volume":"14","author":"Deng","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2025.218183_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107450","article-title":"Targeting ATR as cancer therapy: a new era for synthetic lethality and synergistic combinations?","volume":"207","author":"Bradbury","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.canlet.2025.218183_bib29","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1080\/15384101.2021.1938813","article-title":"Activation of CDC25A phosphatase is limited by CDK2\/cyclin A-mediated feedback inhibition","volume":"20","author":"Ditano","year":"2021","journal-title":"Cell Cycle"},{"key":"10.1016\/j.canlet.2025.218183_bib30","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.canlet.2020.09.016","article-title":"Reality CHEK: understanding the biology and clinical potential of CHK1","volume":"497","author":"Neizer-Ashun","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.218183_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.718636","article-title":"Biological adaptations of tumor cells to radiation therapy","volume":"11","author":"Carlos-Reyes","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2025.218183_bib32","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00018-009-8736-z","article-title":"Base excision repair: the long and short of it","volume":"66","author":"Robertson","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.canlet.2025.218183_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.01009","article-title":"Altering DNA repair to improve radiation therapy: specific and multiple pathway targeting","volume":"9","author":"Biau","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2025.218183_bib34","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s12276-021-00557-3","article-title":"Alternate therapeutic pathways for PARP inhibitors and potential mechanisms of resistance","volume":"53","author":"Kim","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.canlet.2025.218183_bib35","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.clon.2020.12.006","article-title":"Radiobiology summaries: DNA damage and repair","volume":"33","author":"Chalmers","year":"2021","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.canlet.2025.218183_bib36","doi-asserted-by":"crossref","DOI":"10.1186\/s12915-021-00965-x","article-title":"Sustained CHK2 activity, but not ATM activity, is critical to maintain a G1 arrest after DNA damage in untransformed cells","volume":"19","author":"Garc\u00eda-Santisteban","year":"2021","journal-title":"BMC Biol."},{"key":"10.1016\/j.canlet.2025.218183_bib37","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/170325","article-title":"New insights into p53 signaling and cancer cell response to DNA damage: implications for cancer therapy","volume":"2012","author":"Mirzayans","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.canlet.2025.218183_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17010102","article-title":"Cellular pathways in response to ionizing radiation and their targetability for tumor radiosensitization","volume":"17","author":"Maier","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2025.218183_bib39","doi-asserted-by":"crossref","first-page":"30638","DOI":"10.1074\/jbc.M005437200","article-title":"p21 inhibits Thr161 phosphorylation of Cdc2 to enforce the G2 DNA damage checkpoint","volume":"275","author":"Smits","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.canlet.2025.218183_bib40","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrm.2017.53","article-title":"The multifaceted roles of PARP1 in DNA repair and chromatin remodelling","volume":"18","author":"Ray Chaudhuri","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2025.218183_bib41","doi-asserted-by":"crossref","first-page":"204","DOI":"10.20517\/jtgg.2021.61","article-title":"The DNA damage response - from cell biology to human disease","volume":"6","author":"Lam","year":"2022","journal-title":"J. Transl. Genet. Genom."},{"key":"10.1016\/j.canlet.2025.218183_bib42","article-title":"Overcoming therapeutic resistance in pancreatic cancer: emerging opportunities by targeting BRCAs and p53","volume":"1878","author":"Calheiros","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.canlet.2025.218183_bib43","doi-asserted-by":"crossref","first-page":"S822","DOI":"10.21037\/tcr.2017.05.22","article-title":"Repurposing DNA repair factors to eradicate tumor cells upon radiotherapy","volume":"6","author":"Bhattacharya","year":"2017","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.canlet.2025.218183_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-021-00648-7","article-title":"DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2025.218183_bib45","doi-asserted-by":"crossref","first-page":"11135","DOI":"10.1074\/jbc.M113.457440","article-title":"RIF1 counteracts BRCA1-mediated end resection during DNA repair","volume":"288","author":"Feng","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2025.218183_bib46","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1126\/science.1261971","article-title":"PAXX, a paralog of XRCC4 and XLF, interacts with Ku to promote DNA double-strand break repair","volume":"347","author":"Ochi","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.canlet.2025.218183_bib47","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.molcel.2017.05.015","article-title":"ATM, ATR, and DNA-PK: the trinity at the heart of the DNA damage response","volume":"66","author":"Blackford","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2025.218183_bib48","author":"Zhao"},{"key":"10.1016\/j.canlet.2025.218183_bib49","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13148-021-01111-8","article-title":"Epigenetic mechanisms underlying prostate cancer radioresistance","volume":"13","author":"Macedo-Silva","year":"2021","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.canlet.2025.218183_bib50","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/jcb.30361","article-title":"Mechanisms of radioresistance and the underlying signaling pathways in colorectal cancer cells","volume":"124","author":"Tessmann","year":"2023","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.canlet.2025.218183_bib51","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/s41585-023-00726-1","article-title":"Preclinical models of prostate cancer \u2014 modelling androgen dependency and castration resistance in vitro, ex vivo and in vivo","volume":"20","author":"Germain","year":"2023","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.canlet.2025.218183_bib52","first-page":"1839","article-title":"Radioresistance in hepatocellular carcinoma: biological bases and therapeutic implications","author":"Ponziani","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2025.218183_bib53","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1158\/2159-8290.CD-12-0120","article-title":"Dual roles of PARP-1 promote cancer growth and progression","volume":"2","author":"Schiewer","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2025.218183_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.00128","article-title":"Combination therapy with charged particles and molecular targeting: a promising avenue to overcome radioresistance","volume":"10","author":"Konings","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2025.218183_bib55","doi-asserted-by":"crossref","DOI":"10.1177\/17588359241258443","article-title":"Androgen receptor, PARP signaling, and tumor microenvironment: the \u2018perfect triad\u2019 in prostate cancer?","volume":"16","author":"Garofoli","year":"2024","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2025.218183_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-020-00956-5","article-title":"Advances in synthetic lethality for cancer therapy: cellular mechanism and clinical translation","volume":"13","author":"Topatana","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2025.218183_bib57","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.canlet.2018.03.007","article-title":"BCL2-overexpressing prostate cancer cells rely on PARP1-dependent end-joining and are sensitive to combined PARP inhibitor and radiation therapy","volume":"423","author":"Oing","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.218183_bib58","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.radonc.2015.08.003","article-title":"In vivo studies of the PARP inhibitor, AZD-2281, in combination with fractionated radiotherapy: an exploration of the therapeutic ratio","volume":"116","author":"Gani","year":"2015","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.canlet.2025.218183_bib59","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1158\/1535-7163.MCT-16-0740","article-title":"Nanoformulation of olaparib amplifies PARP inhibition and sensitizes PTEN\/TP53-deficient prostate cancer to radiation","volume":"16","author":"Van De Ven","year":"2017","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.canlet.2025.218183_bib60","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ctrv.2009.12.006","article-title":"Human AP endonuclease 1 (APE1): from mechanistic insights to druggable target in cancer","volume":"36","author":"Abbotts","year":"2010","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.canlet.2025.218183_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101749","article-title":"APE1 promotes radiation resistance against radiation-induced pyroptosis by inhibiting the STING pathway in lung adenocarcinoma","volume":"36","author":"Zhou","year":"2023","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.canlet.2025.218183_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-021-02006-5","article-title":"Inhibiting the redox function of APE1 suppresses cervical cancer metastasis via disengagement of ZEB1 from E-cadherin in EMT","volume":"40","author":"Li","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2025.218183_bib63","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jdermsci.2020.08.012","article-title":"APE1 promotes proliferation and migration of cutaneous squamous cell carcinoma","volume":"100","author":"Deng","year":"2020","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.canlet.2025.218183_bib64","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1269\/jrr.09077","article-title":"Radiation resistance in glioma cells determined by DNA damage repair activity of Ape1\/Ref-1","volume":"51","author":"Naidu","year":"2010","journal-title":"J. Radiat. Res."},{"key":"10.1016\/j.canlet.2025.218183_bib65","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4103\/jrcr.jrcr_8_18","article-title":"Apurinic\/apyrimidinic endonuclease 1 performs multiple roles in controlling the outcome of cancer cells toward radiation and chemotherapeutic agents","volume":"9","author":"Ramotar","year":"2018","journal-title":"J. Radiat. Cancer Res."},{"key":"10.1016\/j.canlet.2025.218183_bib66","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1089\/cbr.2012.1266","article-title":"Downregulation of Apurinic\/Apyrimidinic endonuclease 1\/Redox Factor-1 enhances the sensitivity of human pancreatic cancer cells to radiotherapy in vitro","volume":"28","author":"Chen","year":"2013","journal-title":"Cancer Biotherapy and Radiopharmaceuticals"},{"key":"10.1016\/j.canlet.2025.218183_bib67","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1158\/1535-7163.197.4.2","article-title":"(\u2212)-Gossypol enhances response to radiation therapy and results in tumor regression of human prostate cancer","volume":"4","author":"Xu","year":"2005","journal-title":"Mol. Cancer Therapeut."},{"issue":"9","key":"10.1016\/j.canlet.2025.218183_bib68","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/bjc.1998.641","article-title":"Levels of the DNA repair enzyme human apurinic\/apyrimidinic endonuclease (APE1, APEX, Ref-1) are associated with the intrinsic radiosensitivity of cervical cancers","volume":"78","author":"Herring","year":"1998","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2025.218183_bib69","first-page":"991","article-title":"Perspectives on the role of isoflavones in prostate cancer","volume":"15","author":"Ahmad","year":"2013","journal-title":"The APPS J."},{"key":"10.1016\/j.canlet.2025.218183_bib70","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/JTO.0b013e31821034ae","article-title":"Soy isoflavones augment radiation effect by inhibiting APE1\/Ref-1 DNA repair activity in non-small cell lung cancer","volume":"6","author":"Singh-Gupta","year":"2011","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.canlet.2025.218183_bib71","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1158\/2159-8290.CD-14-0358","article-title":"Beyond DNA repair: DNA-PK function in cancer","volume":"4","author":"Goodwin","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2025.218183_bib72","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ccell.2015.06.004","article-title":"DNA-PKcs-Mediated transcriptional regulation drives prostate cancer progression and metastasis","volume":"28","author":"Goodwin","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2025.218183_bib73","doi-asserted-by":"crossref","first-page":"111.e15","DOI":"10.1016\/j.urolonc.2016.10.012","article-title":"Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer","volume":"35","author":"Zhang","year":"2017","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.canlet.2025.218183_bib74","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.3892\/or.2017.5634","article-title":"PRKDC regulates chemosensitivity and is a potential prognostic and predictive marker of response to adjuvant chemotherapy in breast cancer patients","volume":"37","author":"Sun","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2025.218183_bib75","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.bbacli.2014.08.001","article-title":"ATM, ATR and DNA-PKcs expressions correlate to adverse clinical outcomes in epithelial ovarian cancers","volume":"2","author":"Abdel-Fatah","year":"2014","journal-title":"BBA Clin."},{"key":"10.1016\/j.canlet.2025.218183_bib76","doi-asserted-by":"crossref","first-page":"5622","DOI":"10.7150\/jca.58824","article-title":"NEAT1\/miR-101-dependent Up-regulation of DNA-PKcs enhances malignant behaviors of pancreatic ductal adenocarcinoma cells","volume":"12","author":"Hu","year":"2021","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2025.218183_bib77","first-page":"1","article-title":"Secrets of DNA-PKcs beyond DNA repair","volume":"8","author":"Camfield","year":"2024","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.canlet.2025.218183_bib78","doi-asserted-by":"crossref","DOI":"10.3390\/genes10010025","article-title":"Targeting DNA double-strand break repair pathways to improve radiotherapy response","volume":"10","author":"Toulany","year":"2019","journal-title":"Genes"},{"key":"10.1016\/j.canlet.2025.218183_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.102217","article-title":"Phase I study of peposertib and avelumab with or without palliative radiotherapy in patients with advanced solid tumors","volume":"9","author":"Perez","year":"2024","journal-title":"ESMO Open"},{"key":"10.1016\/j.canlet.2025.218183_bib80","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1158\/1535-7163.MCT-23-0681","article-title":"Radiation and chemo-sensitizing effects of DNA-PK inhibitors are proportional in tumors and normal tissues","volume":"23","author":"Baker","year":"2024","journal-title":"Mol. Cancer Therapeut."},{"issue":"10","key":"10.1016\/j.canlet.2025.218183_bib81","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.415","article-title":"PI3K\/Akt\/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathways","volume":"5","author":"Chang","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2025.218183_bib82","first-page":"63","article-title":"Profiling of a panel of radioresistant prostate cancer cells identifies deregulation of key miRNAs","volume":"2","author":"McDermott","year":"2017","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"10.1016\/j.canlet.2025.218183_bib83","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a012716","article-title":"DNA damage sensing by the ATM and ATR kinases","volume":"5","author":"Mar\u00e9chal","year":"2013","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.canlet.2025.218183_bib84","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21218273","article-title":"Targeting DNA damage response in prostate and breast cancer","volume":"21","author":"Wengner","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2025.218183_bib85","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3390\/cancers13010079","article-title":"ATM kinase inhibition preferentially sensitises PTEN-deficient prostate tumour cells to ionising radiation","volume":"13","author":"Hanna","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2025.218183_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103662","article-title":"Targeting ATM and ATR for cancer therapeutics: inhibitors in clinic","volume":"28","author":"Priya","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.canlet.2025.218183_bib87","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1158\/1535-7163.MCT-19-0019","article-title":"The novel ATR inhibitor BAY 1895344 is efficacious as monotherapy and combined with DNA damage\u2013inducing or repair\u2013compromising therapies in preclinical cancer models","volume":"19","author":"Wengner","year":"2020","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.canlet.2025.218183_bib88","article-title":"BRCA1\/P53: two strengths in cancer chemoprevention","volume":"1873","author":"Raimundo","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.canlet.2025.218183_bib89","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016600","article-title":"Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins","volume":"7","author":"Prakash","year":"2015","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.canlet.2025.218183_bib90","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1158\/2159-8290.CD-13-0172","article-title":"Androgen receptor signaling regulates DNA repair in prostate cancers","volume":"3","author":"Polkinghorn","year":"2013","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2025.218183_bib91","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.3390\/cancers14184441","article-title":"Androgen receptor splice variants contribute to the upregulation of DNA repair in prostate cancer","volume":"14","author":"Tolkach","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2025.218183_bib92","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1111\/bph.15506","article-title":"BBIT20 inhibits homologous DNA repair with disruption of the BRCA1\u2013BARD1 interaction in breast and ovarian cancer","volume":"178","author":"Raimundo","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.canlet.2025.218183_bib93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-025-03389-5","article-title":"A first-in-class inhibitor of homologous recombination DNA repair counteracts tumour growth, metastasis and therapeutic resistance in pancreatic cancer","volume":"44","author":"Calheiros","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2025.218183_bib94","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.3390\/ijms22084134","article-title":"The multifaceted roles of Ku70\/80","volume":"22","author":"Zahid","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2025.218183_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120031","article-title":"EGFR-mediated Rad51 expression potentiates intrinsic resistance in prostate cancer via EMT and DNA repair pathways","volume":"286","author":"Rajput","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.canlet.2025.218183_bib96","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.stemcr.2016.12.005","article-title":"RAD51 is a selective DNA repair target to radiosensitize glioma stem cells","volume":"8","author":"King","year":"2017","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.canlet.2025.218183_bib97","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-016-2647-9","article-title":"A radiosensitizing effect of RAD51 inhibition in glioblastoma stem-like cells","volume":"16","author":"Balbous","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2025.218183_bib98","doi-asserted-by":"crossref","DOI":"10.3892\/br.2023.1610","article-title":"DNA-PKcs phosphorylation specific inhibitor, NU7441, enhances the radiosensitivity of clinically relevant radioresistant oral squamous cell carcinoma cells","volume":"18","author":"Ohuchi","year":"2023","journal-title":"Biomed. Rep."},{"key":"10.1016\/j.canlet.2025.218183_bib99","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.3724\/abbs.2022153","article-title":"Triple kill: DDR inhibitors, radiotherapy and immunotherapy leave cancer cells with no escape: DDR inhibitors, radiotherapy and immunotherapy can kill cancer cells","volume":"54","author":"Qiu","year":"2022","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.canlet.2025.218183_bib100","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/j.molcel.2022.03.034","article-title":"Cytoplasmic PARP1 links the genome instability to the inhibition of antiviral immunity through PARylating cGAS","volume":"82","author":"Wang","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2025.218183_bib101","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ijrobp.2020.01.030","article-title":"Combination therapy with radiation and PARP inhibition enhances responsiveness to anti-PD-1 therapy in colorectal tumor models","volume":"108","author":"Seyedin","year":"2020","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canlet.2025.218183_bib102","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.60637","article-title":"PARP1 inhibitors trigger innate immunity via PARP1 trapping-induced DNA damage response","volume":"9","author":"Kim","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.canlet.2025.218183_bib103","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1158\/1541-7786.MCR-21-0725","article-title":"DNA-PK inhibition and radiation promote antitumoral immunity through RNA polymerase III in pancreatic cancer","volume":"20","author":"Wang","year":"2022","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.canlet.2025.218183_bib104","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.168824","article-title":"Potentiating the radiation-induced type I interferon antitumoral immune response by ATM inhibition in pancreatic cancer","volume":"9","author":"Zhang","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.canlet.2025.218183_bib105","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/imm.13602","article-title":"Ataxia telangiectasia mutated kinase inhibition promotes irradiation-induced PD-L1 expression in tumour-associated macrophages through IFN-I\/JAK signalling pathway","volume":"168","author":"Gao","year":"2023","journal-title":"Immunology"},{"key":"10.1016\/j.canlet.2025.218183_bib106","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000340","article-title":"ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma","volume":"8","author":"Sheng","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2025.218183_bib107","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw199","article-title":"Activation of STING-dependent innate immune signaling by S-Phase-Specific DNA damage in breast cancer","volume":"109","author":"Parkes","year":"2017","journal-title":"JNCI: J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2025.218183_bib108","doi-asserted-by":"crossref","first-page":"13587","DOI":"10.18632\/oncotarget.7277","article-title":"Association and prognostic significance of BRCA1\/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1\/PD-L1 in high grade serous ovarian cancer","volume":"7","author":"Strickland","year":"2016","journal-title":"Oncotarget"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525007554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525007554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:43:19Z","timestamp":1792096999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383525007554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":108,"alternative-id":["S0304383525007554"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2025.218183","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overcoming radioresistance in prostate cancer by targeting DNA damage repair","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2025.218183","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218183"}}